ArticleJACS Au2025
Structure-Activity Optimization of Phenoxy-1,2-dioxetane Precursors as Probes for Singlet Oxygen Yields Unprecedented Detection Sensitivity.
Article in JACS Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Recent advances in chemiluminescence probes for Tumor microenvironment with applications in cancer diagnosis and therapy.Pharmaceutical science advances · 2026Review
- Electronegatively substituted adamantyl units accelerate chemiexcitation of 1,2-dioxetane luminophores while preserving chemical stability.Chemical science · 2026Article
- Phosphorylated Chemiluminescent Probe Based on Spiro-cyclobutyl-phenoxy-dioxetane for the In Situ Light-Activated Sensing of Alkaline Phosphatase.Analytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemiluminescence imaging has emerged as a powerful alternative to fluorescence-based methods, offering significant advantages such as reduced background noise, elimination of autofluorescence, and prevention of photobleaching. These benefits are particularly critical for singlet oxygen detection, where the excitation light in fluorescence techniques can inadvertently generate singlet oxygen, compromising measurement accuracy. Despite this potential, the development of highly sensitive chemiluminescent probes for singlet oxygen detection under physiological conditions remains an urgent challenge. Here, we present a comprehensive structure-activity optimization of phenoxy-1,2-dioxetane precursors as probes for singlet oxygen detection in physiological environments. By systematically evaluating key parameterssteric hindrance at the oxidation site, the chemiexcitation rate of the luminophore, and total light emissionwe significantly increased the detection sensitivity of the singlet oxygen probe. Notably, a cyclobutyl-enolether probe (SOCL-CB) and a dimethyl-enolether probe (SOCL-DM) demonstrated 57-fold and 118-fold higher signal-to-noise (S/N) ratios, respectively, compared to the previously reported chemiluminescent adamantyl-enolether probe (SOCL-AD). The superior detection sensitivity of probe SOCL-DM was validated in an enzymatic model where singlet oxygen production was mediated by horseradish peroxidase. Remarkably, probe SOCL-DM detected singlet oxygen concentrations as low as 127 nM in this system, outperforming the previously reported probe SOCL-AD. These results establish probe SOCL-DM as the most sensitive chemiluminescent probe for singlet oxygen detection under physiological conditions reported to date. This study underscores the potential of chemiluminescent probes like SOCL-DM to facilitate real-time monitoring of singlet oxygen, providing invaluable tools for studying oxidative stress, elucidating cellular processes, and advancing diagnostic applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.